Circulation

NOVEMBER 11, 2024

Emerging evidence suggests that vascular stress from cardiovascular-related co-morbidities promotes microvascular dysfunction, a key component in the development of heart failure with preserved ejection fraction.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Arterioles Heart Failure Risk Factors 40

European Journal of Heart Failure

NOVEMBER 8, 2023

Abstract Aim To examine the ability of serum proteins in predicting future heart failure (HF) events, including HF with reduced or preserved ejection fraction (HFrEF or HFpEF), in relation to event time, and with or without considering established HF-associated clinical variables.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Article Risk Factors 40

DAIC

FEBRUARY 29, 2024

ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

APRIL 2, 2024

Yakubu Bene-Alhasan, MD milla1cf Tue, 04/02/2024 - 12:14 April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those who have never used them, according to one of the largest prospective studies to date investigating possible links between vaping and heart failure.

Heart Failure 105

Heart Failure Preserved Ejection Fraction Research Risk Factors 105

Frontiers in Cardiovascular Medicine

AUGUST 6, 2024

In the short-term it can result in pre-eclampsia, haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, or even hypertension associated acute heart failure, all of which may necessitate pre-term delivery to prevent maternal or neonatal death.

Heart Failure 40

Heart Failure Preserved Ejection Fraction Coronary Artery Disease Hypertension 40

Journal of the American Heart Association

JANUARY 16, 2025

BackgroundThe purpose of this study was to investigate whether circulating pyruvate kinase M2 (PKM2) levels are elevated in the peripheral blood and to assess their association with diagnosis and prognosis in patients with heart failure (HF).Methods Patients with HF had higher PKM2 levels than controls (17.44.1 versus 7.82.3

Cardiac Function 45

Cardiac Function Heart Failure Biomarkers Preserved Ejection Fraction 45

Cardiometabolic Health Congress

JULY 25, 2023

Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1]

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

European Journal of Heart Failure

JANUARY 8, 2025

In this cohort study, metabolic dysfunction-associated steatotic liver disease (MASLD) was associated with a higher risk of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). There was a dose-dependent relationship between cardiometabolic risk factors and HF.

Preserved Ejection Fraction 76

Preserved Ejection Fraction Heart Failure Risk Factors Hospital 76

Cardiometabolic Health Congress

NOVEMBER 14, 2024

42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103